MSB 7.69% $1.19 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-339

  1. 7,881 Posts.
    lightbulb Created with Sketch. 624
    That might be the path they take as the meeting with the FDA might coincide with the unbinding of the RCT trial results
    Fingers crossed it all aligns
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.